In addition, The AMPK/PGC-1α/TFAM pathway was effectively inhibited by Compound C, supporting the hypothesis that EA may exert its effects on skeletal muscle glucose metabolism in T2DM via this axis. The gene discussed is PPARGC1A; the disease is type 2 diabetes mellitus.